T1	p 23 39	asthma in adults
T2	p 230 257	31 adult asthmatic patients
T3	i 46 65	sodium cromoglycate
T4	i 122 141	Sodium cromoglycate
T5	i 205 212	placebo
T6	i 311 330	Sodium cromoglycate
T7	i 347 354	placebo
T8	i 769 788	sodium cromoglycate
T9	i 933 952	sodium cromoglycate
T10	i 975 982	placebo
T11	i 1053 1072	sodium cromoglycate
T12	i 1136 1143	placebo
T13	o 368 390	breathlessness at rest
T14	o 415 441	breathlessness on exertion
T15	o 471 487	quality of sleep
T16	o 538 577	morning peak expiratory flow rate value
T17	o 715 736	treatment preferences
T18	o 988 1000	side-effects
T19	o 1168 1186	asthmatic symptoms
T20	o 1236 1267	bronchodilator therapy required